Global Clinical Software Market Overview:
Clinical software is specialized software used by healthcare providers to manage their patient's workflow. COVID-19 pandemic has disrupted global markets, industries, hospitals, and sectors. That affects staff shortage, and supply chain disruptions. Clinical software improved new technologies such as cloud-based solutions, biometric devices, Artificial Intelligence (AI), advanced analytics, connected devices, and wearables become more widely adopted.
- Rising prevalence of infectious, chronic, and rare diseases
- Increasing demand for remote monitoring
- High cost
- Lack of technical competence among healthcare sectors
- Pharmaceutical and healthcare industry are increasingly focusing on clinical software that drives clinical outcome which improves effectiveness during the forecast period
- Innovative technologies such as remote monitoring, remote collaboration, automated data collection and analysis, and others
- Delays caused by disconnected systems, redundant workflows, and manual data re-entry
Companies in the market are concentrating on healthcare services and software. North America is expected largest region for clinical software due to increasing aging populations, increasing prevalence of chronic and infectious diseases, and rising expenditures on research and development sectors. The rapid adoption of digital technologies, increasing preference for digital software, and rising number of research activities drive the market for this region.
Some of the key players profiled in the report are Medidata Solutions Inc. (United States), International Machine Business Corporation (IBM) (United States), Oracle Corporation (India), Parexel International Corp. (United States), RealTime Software Solutions LLC (United States), BioClinica Inc. (United States), MasterControl Inc. (United States), MedNet Solutions Inc. (United States), Veeva Systems Inc. (United States), ArisGlobal LLC (United States), Cerner Corporation (United States), Athenahealth (India) and Softeq (United States). Additionally, following companies can also be profiled that are part of our coverage like Allscripts (United States) and CompuGroup (Germany). Analyst at AMA Research see United States Players to retain maximum share of Global Clinical Software market by 2026. Considering Market by End-Use Industries , the sub-segment i.e. Pharmaceutical will boost the Clinical Software market. Considering Market by Deployment, the sub-segment i.e. On-Cloud will boost the Clinical Software market. Considering Market by Delivery, the sub-segment i.e. Web-Based will boost the Clinical Software market.
Oct 6, 2021: Medidata Solution Inc. launched Medidata Sensor Cloud Network. This software is used to focus on solving challenges related to sensor integrations, standardization of sensor data, and the development of digital biomarkers and algorithms.
What Can be Explored with the Clinical Software Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Clinical Software Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Clinical Software
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Clinical Software market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Clinical Software market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Government Agency/Government, Medical Centres, Healthcare Systems, End-Use Industries and Research & Development.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Frequently Asked Questions (FAQ):1. What is the growth rate predicted for the Global Clinical Software Market?
The Clinical Software market is expected to see a CAGR of % during projected year 2020 to 2026.
2. Who are the top performing companies in Clinical Software Market?
Top performing companies in the Global Clinical Software market are Medidata Solutions Inc. (United States), International Machine Business Corporation (IBM) (United States), Oracle Corporation (India), Parexel International Corp. (United States), RealTime Software Solutions LLC (United States), BioClinica Inc. (United States), MasterControl Inc. (United States), MedNet Solutions Inc. (United States), Veeva Systems Inc. (United States), ArisGlobal LLC (United States), Cerner Corporation (United States), Athenahealth (India) and Softeq (United States), to name a few.
3. What trending factors would impact Clinical Software Market growth most?
"Enhance patient experience
" is seen as one of major influencing trends for Clinical Software Market during projected period 2020-2026.